A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum
Open Access
- 20 October 2025
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (49) , e202514085
Abstract
The emergence of drug resistance to nearly all antimalarials following their rollout underscores the need for novel chemotypes with novel modes of action to replenish the antimalarial drug‐development pipeline. We identified a novel class of compounds in the antimalarial armory. Compound 31 , characterized by a 2‐hydroxyphenyl benzamide scaffold, displays potent activity against blood‐stage and mature sexual stages of Plasmodium falciparum and no toxicity in human cells. Resistance selection studies with 31 identified a previously unknown point mutation in the P. falciparum multidrug‐resistance protein 1 ( pfmdr1 ) gene, for which we confirmed causality by CRISPR/Cas9‐based gene editing as the primary mediator of resistance. No cross‐resistance toward first‐line antimalarials was identified in compound 31 ‐resistant parasites. Proteomics studies indicated that the primary mode of action of 31 is through direct binding to cytosolic ribosomal subunits, thereby inhibiting protein synthesis in the parasite. Taken together, compound 31 is a promising starting point for the development of a next‐generation antimalarial.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (860816)
This publication has 27 references indexed in Scilit:
- An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugsNature Communications, 2025
- Integral Solvent-Induced Protein Precipitation for Target-Engagement Studies in Plasmodium falciparumACS Infectious Diseases, 2024
- Targeting Plasmodium falciparum IspD in the Methyl-d-erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell ActivityJournal of Medicinal Chemistry, 2024
- Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug DiscoveryACS Infectious Diseases, 2018
- DNA damage regulation and its role in drug-related phenotypes in the malaria parasitesScientific Reports, 2016
- A novel multiple-stage antimalarial agent that inhibits protein synthesisNature, 2015
- Artemisinin resistance: current status and scenarios for containmentNature Reviews Microbiology, 2010
- SUnSET, a nonradioactive method to monitor protein synthesisNature Methods, 2009
- Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparumThe EMBO Journal, 2006
- The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisininMolecular and Biochemical Parasitology, 2000